Does oral inositol hexakisphosphate reduce intestinal permeability in mouse models of inflammatory bowel disease?
What the Evidence Shows
We analyzed the available evidence on oral inositol hexakisphosphate and intestinal permeability in mouse models of inflammatory bowel disease. What we’ve found so far is that eight studies or assertions support the idea that taking inositol hexakisphosphate by mouth is linked to reduced intestinal...
Evidence from Studies
Supporting (0)
No supporting evidence found
Contradicting (0)
No contradicting evidence found
Primary Studies (1)
Update History
Published
June 8, 2026·Last updated June 8, 2026- Invalid DateNew topic created from assertion